PT027 (budesonide/albuterol)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PT027 (budesonide/albuterol), covering 2025-08-26 to 2025-08-26. Get the full timeline:
Most recent: Clinical Trial Update: Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants. [Phase 1]